If you take steroids for asthma, autoimmune disease, or inflammatory conditions and are considering semaglutide, you need specific guidance on managing both medications safely
For primary and family care, this evolution offers immense potential to address complex, interrelated conditions more effectively
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
In Phase II trials: Efinopegdutide (Merck/Johnson & Johnson/Hanmi Harma), VK2735 (Viking Therapeutics), BGM0504 (BrightGene), Pemvidutide (Altimmune/Spitfire Pharma), AMG133 (Amgen), Dapiglutide (Zealand Pharma), etc